These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1503 related articles for article (PubMed ID: 28295985)

  • 21. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.
    Pascual-Figal DA; Ferrero-Gregori A; Gomez-Otero I; Vazquez R; Delgado-Jimenez J; Alvarez-Garcia J; Gimeno-Blanes JR; Worner-Diz F; Bardají A; Alonso-Pulpon L; Gonzalez-Juanatey JR; Cinca J;
    Int J Cardiol; 2017 Aug; 240():265-270. PubMed ID: 28318662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.
    Hsu JJ; Ziaeian B; Fonarow GC
    JACC Heart Fail; 2017 Nov; 5(11):763-771. PubMed ID: 29032140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
    Steinmann E; Brunner-La Rocca HP; Maeder MT; Kaufmann BA; Pfisterer M; Rickenbacher P
    Eur J Intern Med; 2018 Nov; 57():61-69. PubMed ID: 29908708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.
    Gómez-Otero I; Ferrero-Gregori A; Varela Román A; Seijas Amigo J; Pascual-Figal DA; Delgado Jiménez J; Álvarez-García J; Fernández-Avilés F; Worner Diz F; Alonso-Pulpón L; Cinca J; Gónzalez-Juanatey JR;
    Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):338-346. PubMed ID: 28011188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.
    Ibrahim NE; Song Y; Cannon CP; Doros G; Russo P; Ponirakis A; Alexanian C; Januzzi JL
    ESC Heart Fail; 2019 Aug; 6(4):784-792. PubMed ID: 31268631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
    Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.
    Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P;
    Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Long-Term Outcomes of Patients with Acute Decompensated Heart Failure with Mid-Range Ejection Fraction.
    Ito M; Wada H; Sakakura K; Ibe T; Ugata Y; Fujita H; Momomura SI
    Int Heart J; 2019 Jul; 60(4):862-869. PubMed ID: 31204376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
    Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.
    Rastogi A; Novak E; Platts AE; Mann DL
    Eur J Heart Fail; 2017 Dec; 19(12):1597-1605. PubMed ID: 29024350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
    Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
    Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
    Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
    Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
    Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
    ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.